Congressional coalition rallies against CMS ban on pharmacy home deliveries of diabetes testing supplies

News
Article

Forty-three members of Congress are urging the Centers for Medicare and Medicaid Services (CMS) not to implement a new policy that prohibits independent community pharmacies from providing same-day, home delivery of diabetes testing supplies (DTS) to homebound seniors.

 

Forty-three members of Congress are urging the Centers for Medicare and Medicaid Services (CMS) not to implement a new policy that prohibits independent community pharmacies from providing same-day, home delivery of diabetes testing supplies (DTS) to homebound seniors.

 

The policy is scheduled to take effect July 1, 2013. It was designed to prevent large drug suppliers from circumventing the mail-order process to get higher reimbursements. However, that loophole will be eliminated in July when the government adopts uniform payment rates to both mail-order and retail pharmacies.

 

"We write to request that the Centers for Medicare and Medicaid Services reconsider its decision to no longer allow small community pharmacies to deliver diabetes testing supplies (DTS) to homebound patients as well as patients in long term care and assisted living facilities," the lawmakers wrote in a May 21 letter to CMS. "This policy will cause disruption in the care provided to Medicare patients.”

 

"Now that retail and mail-order suppliers receive the same level of reimbursements, we believe there is no further reason to prohibit home delivery by retail pharmacies," the letter concluded. "We ask that you expeditiously consider allowing small retail pharmacies to continue home delivery and not prevent these crucial, face-to-face counseling and adherence services from being available to Medicare patients."

 

Pharmacists and lawmakers fear the change will force some independents to stop offering DTS. “This absurd policy of banning pharmacy deliveries to vulnerable patients is indefensible and must be overturned,” said B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association. “For pharmacists, it adds insult to injury, coming on top of the reimbursement cuts. For patients accustomed to the deliveries, it represents a needless hurdle in their efforts to combat diabetes."


Related Videos
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Video 1 - "The Influence of Social Determinants of Health on Diabetes Care and Outcomes"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 8 - "Demographic Differences That Impact Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.